Bilateral Pallidal Stimulation in a Family With Myoclonus Dystonia Syndrome Due to a Mutation in the Sarcoglycan Gene.

Abstract

OBJECTIVES:

The study aimed to present a family with myoclonus dystonia (M-D) syndrome due to a mutation in the epsilon sarcoglycan gene (SGCE). Three members of the family suffered from treatment-refractory severe myoclonic jerks of the neck, trunk, and upper extremities. The mild dystonic symptoms recognized as cervical dystonia or truncal dystonia affected all individuals. The efficacy of pharmacotherapy, including anticholinergic, dopaminergic, and serotoninergic drugs, has failed. One individual developed an alcohol dependency and suffered from alcoholic epilepsy.

MATERIALS AND METHODS:

The patients were referred for stereotactic surgery. All individuals underwent bilateral implantation of deep brain stimulation (DBS) leads into the posteroventrolateral segment of the globus pallidus internus (GPi). Surgeries were uneventful. The formal preoperative objective assessment included the Unified Myoclonus Rating Scale (UMRS) and the Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS). The postoperative UMRS and BFMDRS assessments were done only under continuous stimulation at 3, 6, and 12 months after the surgery and at the last available follow-up ranging from 6 to 15 months (mean, 10 months follow-up).

RESULTS:

At the last follow-up visit, the rest and action parts of UMRS were improved by 93.3% and 88.2%, respectively, when compared to the baseline scores. The motor and disability scales of BFMDRS were improved by 77% and 43% at the last follow-up visit compared to the baseline BFMDRS scores. There were no hardware or stimulation-induced complications over the follow-up period. Positive social adjustment allowed two patients to regain jobs and one patient continued his education and hobbies.

CONCLUSION:

Our experience gathered in three individuals in the family with a mutation in SGCE indicates that bilateral GPi DBS can be an effective and safe treatment for disabling pharmacological resistant, intractable M-D syndrome.

• Authors: Michał Sobstyl, Angelika Stapińska-Syniec, Jacek Zaremba, Marta Jurek, Anna Kupryjaniuk, Marcin Rylski
• Journal: Neuromodulation : journal of the International Neuromodulation Society (Neuromodulation) Vol. 25 Issue 6 Pg. 918-924 (Aug 2022) ISSN: 1525-1403 [Electronic] United States
• PMID: 33497502 (Publication Type: Journal Article)
• Copyright: Copyright © 2022 International Neuromodulation Society. Published by Elsevier Inc. All rights reserved.

Chemical References

• Sarcoglycans

Topics

• Deep Brain Stimulation
• Dystonia
• Dystonic Disorders (genetics, therapy)
• Globus Pallidus (physiology)
• Humans
• Mutation (genetics)
• Myoclonus
• Sarcoglycans (genetics)
• Treatment Outcome